Boothbay Fund Management »

Crinetics Pharmaceuticals In shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $10M 344k 29.74
2023-06-30 $1.7M 97k 18.02
2020-06-30 $208k 12k 17.55

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr 1 3 Yr Treas Bd Put Option (SHY)
Vmware Cl A Com Call Option
Activision Blizzard
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Sarepta Therapeutics (SRPT)
Cornerstone Strategic Value (CLM)
Zimmer Holdings (ZBH)
Synopsys Put Option (SNPS)
Sprott Physical Gold & Silve Tr Unit (CEF)
Argenx Se Sponsored Adr (ARGX)
Select Sector Spdr Tr Indl Put Option (XLI)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Elanco Animal Health (ELAN)

View all positions for Boothbay Fund Management

Top funds holding Crinetics Pharmaceuticals In

Vanguard Group
Point72 Asset Management
Wellington Management Company
T. Rowe Price Associates
Jennison Associates
Paradigm Biocapital Advisors
EcoR1 Capital
First Light Asset Management
OrbiMed Advisors
Perceptive Advisors
Cormorant Asset Management
Eventide Asset Management
Ikarian Capital
Lord, Abbett & Co
Dimensional Fund Advisors

View all funds holding Crinetics Pharmaceuticals In